| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;107:1937.)
© 2003 American Heart Association, Inc.
Basic Science Reports |
From RIEM, Nagoya University, Nagoya, Japan (H.H., R.N., M.Y., T.H., K.K., I.K.); School of Biomedical Sciences, University of Leeds, Leeds, UK (M.R.B.); School of Engineering, Tokyo Denki University, Tokyo, Japan (S.I., K.M.); and Tokyo Womens Medical University, Tokyo, Japan (N.S.).
Correspondence to Dr Haruo Honjo, Research Institute of Environmental Medicine, Nagoya University, Nagoya 464-8601, Japan. E-mail honjo{at}riem.nagoya-u.ac.jp
| Abstract |
|---|
|
|
|---|
Methods and Results Extracellular potential mapping of rabbit right atrial preparations showed that ryanodine (2 µmol/L) caused a shift of the leading pacemaker from the sinoatrial node to an ectopic focus near the right PV-atrium junction. The transmembrane potential recorded from the isolated myocardial sleeve of the right PV showed typical atrial-type action potentials with a stable resting potential under control conditions. Treatment with ryanodine (0.5 to 2 µmol/L) resulted in a depolarization of the resting potential and a development of pacemaker depolarization. These changes were enhanced transiently after an increase in the pacing rate: a self-terminating burst of spontaneous action potentials (duration, 33.6±5.0 s; n=32) was induced by a train of rapid stimuli (3.3 Hz) applied after a brief rest period. The pacing-induced activity was attenuated by either depletion of the sarcoplasmic reticulum of Ca2+ or blockade of the sarcolemmal Na+-Ca2+ exchanger or Cl- channels and potentiated by ß-adrenergic stimulation.
Conclusions PV myocardial sleeves have the potential to generate spontaneous activity, and such arrhythmogenic activity is uncovered by modulation of intracellular Ca2+ dynamics.
Key Words: electrophysiology fibrillation veins action potentials
| Introduction |
|---|
|
|
|---|
The myocardial fibers of the left atrium wrap around the PVs entering the left atrium to form "myocardial sleeves" (MSs),6,7 and this structure is the origin of focal activity.8 Previous studies have suggested that PVMSs show a variety of spontaneous activities such as sinoatrial (SA) node-type automaticity, rapid spontaneous activities via early or delayed afterdepolarizations,812 and microreentry based on a marked heterogeneous tissue structure.12,13 However, the electrophysiological properties of PVMSs have not been fully characterized.
In the present study, we investigated the electrophysiological properties of rabbit PVMSs. The results show that addition of 0.5 to 2 µmol/L ryanodine to PVMSs uncovers pacing-induced spontaneous activity. Ryanodine at low concentrations locks the sarcoplasmic reticulum (SR) Ca2+ release channel, the ryanodine receptor (RyR), in a subconductance state, causing a Ca2+-independent Ca2+ release from the SR.14 Such Ca2+ leakage during diastole may alter intracellular Ca2+ and thus Ca2+-dependent ionic currents,15 and this may be the cause of the spontaneous activity. The results may be important clinically, because remodeling of Ca2+ handling proteins, including RyR, occurs in disease states.16
| Methods |
|---|
|
|
|---|
|
|
Preparations were superfused with Krebs-Ringer solution containing (in mmol/L): 120.3 NaCl, 4.0 KCl, 1.2 CaCl2, 1.3 MgSO4, 1.2 NaH2PO4, 25.2 NaHCO3, and 11.0 glucose (pH 7.4, equilibrated with 95% O2/5% CO2) at 33°C. When Ni2+ was applied, HEPES-buffered solution gassed with 100% O2 was used, with a composition of (in mmol/L): 145.0 NaCl, 4.0 KCl, 1.2 CaCl2, 1.3 MgCl2, 5.0 HEPES, and 11.0 glucose (pH 7.4). Ryanodine (Sigma) was dissolved in water to make a stock solution (5 mmol/L).
Data are presented as mean±SEM. Students t test and ANOVA were used to test differences, and a difference was considered significant at a value of P<0.05.
| Results |
|---|
|
|
|---|
Pacing-Induced Spontaneous Activity
To characterize the electrical properties of the ectopic pacemaker without interference from the SA node, the right superior PVMS was isolated (Figure 2A) and membrane potential recorded. The majority of isolated PVMSs (39 of 41 preparations) were electrically quiescent without stimulation under control conditions, and the remaining 2 showed spontaneous activity. Figure 2B shows the membrane potential during regular pacing (2 Hz) before and after application of ryanodine in a quiescent preparation. Under control conditions, normal atrial-type action potentials were elicited from a stable RP in response to stimuli (Figure 2B). Treatment with ryanodine (0.5 µmol/L) for 30 minutes resulted in an elevation of the action potential plateau, a depolarization of the RP, and a development of pacemaker depolarization (Figure 2B). The pacemaker depolarization could be similar to that in the SA node, or it could be a pacing-induced delayed afterdepolarization such as that described in the coronary sinus.18 These changes were more marked during rapid pacing. Figure 2C shows an example in which a train of rapid stimuli (20 pulses at 3.3 Hz) was applied after a 1-minute rest to a preparation treated with ryanodine (0.5 µmol/L). Rest resulted in a large hyperpolarization of the RP (similar hyperpolarization was seen in preparations including the SA node when the ectopic pacemaker became quiescent after application of ryanodine; Figure 1D). The first action potential during the stimulation train after the rest was atrial-like with a stable RP, although the plateau of the action potential was low and short (Figure 2C). During rapid pacing, there was a broadening of the action potential plateau and a depolarization of the RP (Figure 2C). These changes were associated with a development of pacemaker depolarization, and by the end of pacing, the action potential had been converted from a typical atrial-type to an apparently SA node-type pacemaker action potential (Figure 2C). As a result, spontaneous action potentials developed from the pacemaker depolarization when pacing was stopped (Figure 2C). The slope of the pacemaker depolarization gradually declined during the train of spontaneous action potentials, and the spontaneous activity eventually ceased. Such behavior is analogous to that seen in preparations including the SA node (Figure 1).
Table 1 summarizes the pacing-induced spontaneous activity. A train of 3.3-Hz stimulation (after a 1-minute rest) caused self-terminating spontaneous activity in 82.1% of PVMS preparations after treatment with ryanodine (0.5 to 2 µmol/L; Table 1). A brief rest period before rapid pacing was not essential for the spontaneous activity, and an abrupt increase in the pacing rate (from 0.5 or 1.0 to 3.3 Hz) could also induce the activity in PVMSs treated with ryanodine (Table 1). Spontaneous action potentials were never induced by pacing in the normal atrial muscle of the right and left atrial appendages treated with ryanodine (Table 1).
|
Steady-State Action Potentials
Development of pacemaker depolarization in PVMSs treated with ryanodine was accompanied by changes in the action potential configuration. We examined rate-dependent changes of the steady-state action potential in 6 PVMSs. Representative examples at 3 stimulation rates before and after application of ryanodine (2 µmol/L) are shown in Figure 3A, and changes in action potential parameters are summarized in Figure 3B. Under control conditions, there was a small but significant depolarization of the RP at pacing rates >3.3 Hz (Figure 3B). After treatment with ryanodine (2 µmol/L), there was a greater depolarization of the RP and a reduction of the action potential overshoot at high rates (Figure 3B). The ryanodine-induced depolarization of the RP at 2.0 Hz was significantly larger in PVMSs (9.5±1.1 mV, n=8) than in the normal atrial muscle (5.6±1.9 mV, n=6, P<0.01; Figure 3B). Ryanodine also caused biphasic changes in action potential duration: it was prolonged during pacing at 0.5 to 2 Hz, whereas it was shortened at faster rates (Figure 3B).
|
Effects of Modulation of Intracellular Ca2+ Dynamics
The effect of depletion of SR Ca2+ on the pacing-induced spontaneous activity was examined. Figure 4A shows that an inhibition of the SR Ca2+ pump by cyclopiazonic acid (CPA)19 attenuated the pacing-induced activity. After treatment of a PVMS with ryanodine (2 µmol/L) for 30 minutes, rapid pacing resulted in the development of pacemaker depolarization during pacing and repetitive spontaneous action potentials after pacing (Figure 4A2). These effects were not reversed after wash-off of ryanodine. After addition of CPA (50 µmol/L) to the PVMS treated with ryanodine, the development of pacemaker depolarization was attenuated, and only a few nondriven action potentials were induced (Figure 4A3). These effects of CPA were partially reversed after its wash-off (Figure 4A4). In 4 PVMSs, CPA (50 µmol/L) caused a significant decrease in the duration of the pacing-induced spontaneous activity from 45.8±14.8 to 9.8±5.8 s (P<0.01). In PVMSs pretreated for 30 minutes with thapsigargin (5 to 50 µmol/L), another inhibitor of the SR Ca2+ pump,19 rapid stimulation induced only a few spontaneous action potentials, even after treatment with ryanodine (duration, 5.7±1.3 s; n=4). These results support the hypothesis that pacing-dependent changes in intracellular Ca2+ are involved in the spontaneous activity.
|
There are various Ca2+-regulated ionic currents,15 and the possible contribution of Na+-Ca2+ exchange current and Ca2+-activated Cl- current to the spontaneous activity was investigated. Figure 4B shows the effects of Ni2+ to inhibit the Na+-Ca2+ exchanger.20 Application of Ni2+ (5 mmol/L) abolished the development of the pacemaker depolarization during rapid pacing and spontaneous activity after pacing. It is unlikely that these effects of Ni2+ are the result of its blocking action on Ca2+ current (and a decrease of SR Ca2+ content), because Ni2+ abolished the pacing-induced spontaneous activity (duration, from 35.7±11.1 to 0 s; n=5), whereas a partial block of Ca2+ current by nifedipine (3 µmol/L), which caused a similar shortening of the action potential to that induced by Ni2+, had no appreciable effects on the duration of the activity (from 35.2±9.8 to 29.2±6.3 s, n=4).
Figure 4C shows that niflumate, a Cl- channel blocker,15 attenuated the development of the pacemaker depolarization induced by rapid pacing, and there were no spontaneous action potentials after pacing. The duration of the pacing-induced spontaneous activity was decreased significantly by the Cl- channel blockers, 50 µmol/L niflumate or 100 µmol/L DIDS from 26.2±5.2 to 2.9±1.7 s (n=7, P<0.01). These results suggest that the contribution of the Na+-Ca2+ exchanger is major but that of the Ca2+-activated Cl- channel is also significant in the pacing-induced spontaneous activity.
Effects of ß-Adrenergic Stimulation
Figure 5 shows that isoproterenol (0.1 µmol/L) markedly increased the development of pacemaker depolarization during pacing and prolonged the spontaneous activity after rapid pacing in the PVMSs treated with ryanodine. The duration of the spontaneous activity was significantly increased after application of isoproterenol from 32.1±3.1 to 70.9±38.9 s (n=6, P<0.01). These findings support the hypothesis that the pacing-induced spontaneous activity is the result of changes in intracellular Ca2+ dynamics. Spontaneous action potentials were never induced by rapid pacing in the presence of isoproterenol (0.1 µmol/L) in PVMSs without treatment with ryanodine (n=3).
|
Effects of Strophanthidin
The effects of strophanthidin were investigated on right atrial preparations including the SA node and isolated PVMS. In all the right atrial preparations tested (n=5), strophanthidin (0.1 µmol/L) induced spontaneous activity in an ectopic site close to the PV-atrium junction (Figure 6A), as in the case of ryanodine. Figure 6B shows the effects of strophanthidin (0.1 µmol/L) on the isolated PVMS. In the presence of strophanthidin, a train of rapid pacing at 3.3 Hz induced a short burst of spontaneous action potentials (duration, 3.5±0.8 s; n=4), but the activity induced by strophanthidin was not associated with the development of pacemaker depolarization during diastole.
|
| Discussion |
|---|
|
|
|---|
The fact that the spontaneous activity could be induced only in PVMSs and not in the normal atrial muscle (Table 1) suggests that PVMS cells have distinct electrophysiological characteristics. Chen et al11 reported that canine PVMS cells with spontaneous activity have a significantly lower density of inward rectifier K+ current, IK1. It is well known that SA node cells lack IK1, and this is essential for their normal pacemaking.23 The low density of IK1 may also be an essential feature for the ectopic pacemaker activity of the PVMSs. The present study suggests that Na+-Ca2+ exchange current along with Ca2+-dependent Cl- current may be involved in the spontaneous activity. It is possible that during diastole, these inward currents are able to cause depolarization of the membrane (and thus spontaneous activity) because of the low density of IK1.
The results obtained from rabbit PVMSs may help to explain why AF begets AF.24 When there is already AF (by any mechanism), the high-frequency activity may provoke the arrhythmogenic activity of the PVMSs and thereby initiate another episode of AF. Clinical electrophysiology studies in patients with AF have demonstrated that rapid focal activity originating in one PV can trigger focal activity in another PV to maintain AF.25
Atrial tachyarrhythmias, including AF, are more common under pathological conditions, such as hypertrophy, hyperthyroidism, and heart failure, and these conditions result in a remodeling of Ca2+-handling proteins and thus a modification of intracellular Ca2+ dynamics.16 For example, heart failure is associated with upregulation of the Na+-Ca2+ exchanger and downregulation of SR Ca2+-ATPase, causing an increase in the propensity for intracellular Ca2+ overload.26 In addition, it has recently been reported that in failing hearts, RyR molecules are hyperphosphorylated.27 Hyperphosphorylation of RyR dissociates its stabilizing subunit, FKBP12.6, resulting in altered channel function (increased open probability and subconductance states).27 This is comparable to the action of low concentrations of ryanodine. It is reported that mutations in RyR result in catecholamine-sensitive tachyarrhythmias.28 However, there is no evidence at present for remodeling of intracellular Ca2+ handling in PVMSs of AF patients, and therefore, it is uncertain whether the pacing-induced spontaneous activity observed in this study has any relationship to rapid the PV activity seen in AF patients.
Received September 17, 2002; revision received December 31, 2002; accepted January 7, 2003.
| References |
|---|
|
|
|---|
2. Jaïs P, Haïssaguerre M, Shah DC, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997; 95: 572576.
3. Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998; 339: 659666.
4. Haïssaguerre M, Jaïs P, Shah DC, et al. Catheter ablation of chronic atrial fibrillation targeting the reinitiating triggers. J Cardiovasc Electrophysiol. 2000; 11: 210.[Medline] [Order article via Infotrieve]
5. Chen P-S, Wu T-J, Hwang C, et al. Thoracic veins and the mechanisms of non-paroxysmal atrial fibrillation. Cardiovasc Res. 2002; 54: 295301.
6. Nathan H, Eliakim M. The junction between the left atrium and the pulmonary veins: an anatomic study of human hearts. Circulation. 1966; 34: 412422.
7. Masani F. Node-like cells in the myocardial layer of the pulmonary vein of rats: an ultrastructural study. J Anat. 1986; 145: 133142.[Medline] [Order article via Infotrieve]
8. Chen YJ, Chen SA, Chang MS, et al. Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation. Cardiovasc Res. 2000; 48: 265273.
9. Cheung DW. Pulmonary vein as an ectopic focus in digitalis-induced arrhythmia. Nature. 1981; 294: 582584.[CrossRef][Medline] [Order article via Infotrieve]
10. Cheung DW. Electrical activity of the pulmonary vein and its interaction with the right atrium in the guinea-pig. J Physiol. 1981; 314: 445456.
11. Chen Y-J, Chen S-A, Chen Y-C, et al. Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: implication in initiation of atrial fibrillation. Circulation. 2001; 104: 28492854.
12. de Bakker JMT, Ho SY, Hocini M. Basic and clinical electrophysiology of pulmonary vein ectopy. Cardiovasc Res. 2002; 54: 287294.
13. Hocini M, Ho SY, Kawara T, et al. Electrical conduction in canine pulmonary veins: electrophysiological and anatomical correlation. Circulation. 2001; 105: 24422448.
14. Zucchi R, Ronca-Testoni S. The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol Rev. 1997; 49: 151.
15. Schlotthauser K, Bers DM. Sarcoplasmic reticulum Ca2+ release causes myocardial depolarization: underlying mechanism and threshold for triggered action potentials. Circ Res. 2000; 87: 774780.
16. Tomaselli GF, Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res. 1999; 42: 270283.
17. Shibata N, Inada S, Mitsui K, et al. Pacemaker shift in the rabbit sinoatrial node in response to vagal nerve stimulation. Exp Physiol. 2001; 86: 177184.[Abstract]
18. Aronson RS, Cranefield PF, Wit AL. The effects of caffeine and ryanodine on the electrical activity of the canine coronary sinus. J Physiol. 1985; 368: 593610.
19. Baudet S, Shaoulian R, Bers D. Effects of thapsigargin and cyclopiazonic acid on twitch force and sarcoplasmic reticulum Ca2+ content of rabbit ventricular muscle. Circ Res. 1993; 73: 813819.
20. Sigekawa M, Iwamoto T. Cardiac Na+-Ca2+ exchange: molecular and pharmacological aspects. Circ Res. 2001; 88: 864876.
21. Gorza L, Vitadello M. Distribution of conduction system fibers in the developing and adult rabbit heart revealed by an antineurofilament antibody. Circ Res. 1989; 65: 360369.
22. Blom NA, Gittenberger-de Groot AC, DeRuiter MC, et al. Development of the cardiac conduction tissue in human embryos using HNK-1 antigen expression: possible relevance for understanding of abnormal atrial automaticity. Circulation. 1999; 99: 800806.
23. Boyett MR, Honjo H, Kodama I. The sinoatrial node, a heterogeneous pacemaker structure. Cardiovasc Res. 2000; 47: 658687.
24. Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 1995; 92: 19541968.
25. Kumagai K, Yasuda T, Tojo H, et al. Role of rapid focal activation in the maintenance of atrial fibrillation originating from the pulmonary veins. Pacing Clin Electrophysiol. 2000; 23: 18231827.[Medline] [Order article via Infotrieve]
26. Pogwizd SM, Schlotthauer K, Li L, et al. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual ß-adrenergic responsiveness. Circ Res. 2001; 88: 11591167.
27. Marx SO, Reiken S, Hisamatsu Y, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000; 101: 365376.[CrossRef][Medline] [Order article via Infotrieve]
28. Prior SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002; 106: 6974.
This article has been cited by other articles:
![]() |
G. L. Aistrup, R. Villuendas, J. Ng, A. Gilchrist, T. W. Lynch, D. Gordon, I. Cokic, S. Mottl, R. Zhou, D. A. Dean, et al. Targeted G-protein inhibition as a novel approach to decrease vagal atrial fibrillation by selective parasympathetic attenuation Cardiovasc Res, August 1, 2009; 83(3): 481 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst CHAPTER 29 Atrial Fibrillation ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Mangoni and J. Nargeot Genesis and Regulation of the Heart Automaticity Physiol Rev, July 1, 2008; 88(3): 919 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rostock, D. Steven, B. Lutomsky, H. Servatius, I. Drewitz, H. Klemm, K. Mullerleile, R. Ventura, T. Meinertz, and S. Willems Atrial fibrillation begets atrial fibrillation in the pulmonary veins on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans. J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2153 - 2160. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Knight The pulmonary veins speedy recoveries and early discharges. J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2161 - 2162. [Full Text] [PDF] |
||||
![]() |
S. A. Jones, M. Yamamoto, J. O. Tellez, R. Billeter, M. R. Boyett, H. Honjo, and M. K. Lancaster Distinguishing Properties of Cells From the Myocardial Sleeves of the Pulmonary Veins: A Comparison of Normal and Abnormal Pacemakers Circ Arrhythm Electrophysiol, April 1, 2008; 1(1): 39 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Platoshyn, Y. Yu, E. A Ko, C. V. Remillard, and J. X.-J. Yuan Heterogeneity of hypoxia-mediated decrease in IK(V) and increase in [Ca2+]cyt in pulmonary artery smooth muscle cells Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L402 - L416. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Coutu, D. Chartier, and S. Nattel Comparison of Ca2+-handling properties of canine pulmonary vein and left atrial cardiomyocytes Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2290 - H2300. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamamoto, H. Dobrzynski, J. Tellez, R. Niwa, R. Billeter, H. Honjo, I. Kodama, and M. R. Boyett Extended atrial conduction system characterised by the expression of the HCN4 channel and connexin45 Cardiovasc Res, November 1, 2006; 72(2): 271 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wongcharoen, Y.-C. Chen, Y.-J. Chen, C.-M. Chang, H.-I Yeh, C.-I Lin, and S.-A. Chen Effects of a Na+/Ca2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity Cardiovasc Res, June 1, 2006; 70(3): 497 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Leem, W. T. Kim, J. M. Ha, Y. J. Lee, H. C. Seong, H. Choe, Y. J. Jang, J. B. Youm, and Y. E Earm Simulation of Ca2+-activated Cl- current of cardiomyocytes in rabbit pulmonary vein: implications of subsarcolemmal Ca2+ dynamics Phil Trans R Soc A, May 15, 2006; 364(1842): 1223 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Patterson, R. Lazzara, B. Szabo, H. Liu, D. Tang, Y.-H. Li, B. J. Scherlag, and S. S. Po Sodium-Calcium Exchange Initiated by the Ca2+ Transient: An Arrhythmia Trigger Within Pulmonary Veins J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1196 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qu Critical mass hypothesis revisited: role of dynamical wave stability in spontaneous termination of cardiac fibrillation Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H255 - H263. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Po, Y. Li, D. Tang, H. Liu, N. Geng, W. M. Jackman, B. Scherlag, R. Lazzara, and E. Patterson Rapid and Stable Re-Entry Within the Pulmonary Vein as a Mechanism Initiating Paroxysmal Atrial Fibrillation J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1871 - 1877. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Chou, M. Nihei, S. Zhou, A. Tan, A. Kawase, E. S. Macias, M. C. Fishbein, S.-F. Lin, and P.-S. Chen Intracellular Calcium Dynamics and Anisotropic Reentry in Isolated Canine Pulmonary Veins and Left Atrium Circulation, June 7, 2005; 111(22): 2889 - 2897. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Vest, X. H.T. Wehrens, S. R. Reiken, S. E. Lehnart, D. Dobrev, P. Chandra, P. Danilo, U. Ravens, M. R. Rosen, and A. R. Marks Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation Circulation, April 26, 2005; 111(16): 2025 - 2032. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-J. Cha, J. R. Ehrlich, L. Zhang, D. Chartier, T. K. Leung, and S. Nattel Atrial Tachycardia Remodeling of Pulmonary Vein Cardiomyocytes: Comparison With Left Atrium and Potential Relation to Arrhythmogenesis Circulation, February 15, 2005; 111(6): 728 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Melnyk, J. R. Ehrlich, M. Pourrier, L. Villeneuve, T.-J. Cha, and S. Nattel Comparison of ion channel distribution and expression in cardiomyocytes of canine pulmonary veins versus left atrium Cardiovasc Res, January 1, 2005; 65(1): 104 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Khan Identifying and understanding the role of pulmonary vein activity in atrial fibrillation Cardiovasc Res, December 1, 2004; 64(3): 387 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lombardi, D. Tarricone, F. Tundo, F. Colombo, S. Belletti, and C. Fiorentini Autonomic nervous system and paroxysmal atrial fibrillation: a study based on the analysis of RR interval changes before, during and after paroxysmal atrial fibrillation Eur. Heart J., July 2, 2004; 25(14): 1242 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haissaguerre, P. Sanders, M. Hocini, P. Jais, and J. Clementy Pulmonary veins in the substrate for atrial fibrillation: The "venous wave" hypothesis J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2290 - 2292. [Full Text] [PDF] |
||||
![]() |
C.-C. Chou, S. Zhou, Y. Miyauchi, H.-N. Pak, Y. Okuyama, M. C. Fishbein, H. S. Karagueuzian, and P.-S. Chen Effects of procainamide on electrical activity in thoracic veins and atria in canine model of sustained atrial fibrillation Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1936 - H1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R Ehrlich, T.-J. Cha, L. Zhang, D. Chartier, P. Melnyk, S. H Hohnloser, and S. Nattel Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties J. Physiol., September 15, 2003; 551(3): 801 - 813. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |